Clinical Scorecard: What Holds Back MIGS
At a Glance
| Category | Detail |
|---|---|
| Condition | Glaucoma |
| Key Mechanisms | Minimally Invasive Glaucoma Surgery (MIGS) techniques aim to reduce intraocular pressure (IOP) with a favorable safety profile. |
| Target Population | Patients with glaucoma requiring surgical intervention. |
| Care Setting | Ophthalmology clinics and surgical centers. |
Key Highlights
- MIGS offers significant IOP reduction with excellent safety.
- Hyphema is a common adverse event impacting patient vision early post-surgery.
- Cognitive biases may hinder surgeon adoption of MIGS despite long-term benefits.
- Interventional lasers and drug delivery methods may reduce hyphema risk.
- Surgeons can benefit from reframing risks associated with surgical interventions.
Guideline-Based Recommendations
Diagnosis
- Assess intraocular pressure and visual field loss to diagnose glaucoma.
Management
- Consider MIGS for patients needing surgical intervention for glaucoma.
Monitoring & Follow-up
- Regular follow-up to evaluate IOP and visual function post-MIGS.
Risks
- Be aware of hyphema as a potential complication of MIGS.
Patient & Prescribing Data
Patients with glaucoma considering surgical options.
MIGS procedures may be underutilized due to perceived short-term risks.
Clinical Best Practices
- Educate patients on the risks and benefits of MIGS.
- Utilize shared decision-making models to address patient concerns.
- Encourage surgeons to recognize cognitive biases affecting surgical decisions.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







